Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H1-Antihistamines in Asia, Middle-East and Africa: Results from the AWARE-AMAC study

Chia‐Yu Chu(National Taiwan University Hospital), Elise Dekker(Novartis (Switzerland)), Sigrid Malfait(Novartis (Switzerland)), Fares Zaitoun, Asmara Mubarak(Royal Hospital), Kathryn Cooke(Novartis (Switzerland)), Nancy Agmon‐Levin(Sheba Medical Center), Anwar Al Hammadi, Nilgün Atakan(University Dermatology), Rand Arnaout(Alfaisal University), Susanne Crowe(Swiss Group For Clinical Cancer Research), Suretha Kannenberg(Western Cape Department of Health), Assem Farag(Benha University), Kanokvalai Kulthanan(Siriraj Hospital)
World Allergy Organization Journal
April 1, 2020
10.1016/j.waojou.2020.100117
Cited by 16

Related Papers

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
|The Lancet|2021|538
Urticaria
|Nature Reviews Disease Primers|2022|368
The global burden of chronic urticaria for the patient and society*
|British Journal of Dermatology|2020|351